谷歌浏览器插件
订阅小程序
在清言上使用

SARS-CoV-2 in Zimbabwe: Milestones and Challenges Faced Towards Achieving the Expected 60% Herd Immunity

Vinie Kouamou, Richard Matarise, Elizabeth Dos Santos,Nyasha Elose,Justen Manasa

˜The œPan African medical journal(2021)

引用 3|浏览4
暂无评分
摘要
In response to COVID-19 pandemic, the Zimbabwe government put in place various rigorous measures to curb the spread of the virus. Although roll-out and access to COVID-19 vaccines in Africa have been slow, the World Health Organization (WHO)-led COVID-19 Vaccines Global Access (COVAX) consortium and the African vaccine acquisition task team are striving to provide 720 million doses of COVID-19 vaccines to achieve 60% coverage in Africa by June, 2022. In line with this, the Zimbabwe vaccination programme commenced on the 26th February 2021 and as of 9th June 2021, approximately, 2.6% of the population have been fully vaccinated in the country. Although the COVID-19 pandemic has crippled the economy and caused significant strain on the public health system, much has been done in the country since the first case was recorded (20th March 2020). However, much more needs to be done to finally reach the expected 60% herd immunity by June 2022.
更多
查看译文
关键词
COVID-19,Vaccine,Zimbabwe
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要